PLAY PODCASTS
Can we afford weight-loss drugs for all?

Can we afford weight-loss drugs for all?

Obesity and associated health problems cause a significant burden on health systems, but should weight-loss drugs be offered under our PBS just for weight loss? In Britain, there is to be a trial of the weight loss drug Mounjaro, that will also seek to measure the economic impact of those benefits. Britain's Health Minister argues that weight loss drugs will be '"life-changing, help them get back to work and ease the demands on our NHS". Guests: Dr Norman Swan, co-presenter of ABC Radio National's Health Report, and the podcast 'What's That Rash?' Jonathan Karnon, Professor of Health Economics at Flinders University Nial Wheate, Pharmaceutical Chemist and Professor of Academic Excellence at Macquarie University And the Albanese Government this week announced a crack down on unfair and excessive card surcharges, promising to get a better deal for Australians and small business. The declining use of cash and the rise of electronic payments means more Australians are getting hit by often hidden surcharges. Guest: Brad Kelly, Co-founder of the Independent Payment Forum

The Economy, Stupid · Australian Broadcasting Corporation

October 17, 202429m 4s

Audio is streamed directly from the publisher (mediacore-live-production.akamaized.net) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Obesity and associated health problems cause a significant burden on health systems, but should weight-loss drugs be offered under our PBS just for weight loss?  

In Britain, there is to be a trial of the weight loss drug Mounjaro, that will also seek to measure the economic impact of those benefits.  Britain's Health Minister argues that weight loss drugs will be '"life-changing, help them get back to work and ease the demands on our NHS". 

Guests:

Dr Norman Swan, co-presenter of ABC Radio National's Health Report, and the podcast 'What's That Rash?'

Jonathan Karnon, Professor of Health Economics at Flinders University

Nial Wheate, Pharmaceutical Chemist and Professor of Academic Excellence at Macquarie University 

And the Albanese Government this week announced a crack down on unfair and excessive card surcharges, promising to get a better deal for Australians and small business.  The declining use of cash and the rise of electronic payments means more Australians are getting hit by often hidden surcharges.  

Guest:

Brad Kelly, Co-founder of the Independent Payment Forum

Topics

Weight loss drugs;OzempicWegovyNHS trialPBS and weight loss drugsSemaglutidediabetesOzempic under PBSOzempic rebate for weight losseconomicspharmaceutical benefits schemecard surchargesACCCEli LillyTirzepatideMounjaroZepboundclinical outcomeimproved economic effects of weight lossnational healthcost of obesity to economy